TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
INVO Fertility ( (IVF) ) has provided an update.
On October 16, 2025, an institutional investor of INVO Fertility exercised its Additional Investment Right to acquire 500 shares of Series C-2 Convertible Preferred Stock for $500,000. This transaction adjusted the conversion price to $0.6285 per share and was conducted without registration under the Securities Act, impacting the company’s financial structure and shareholder composition.
The most recent analyst rating on (IVF) stock is a Hold with a $0.50 price target. To see the full list of analyst forecasts on INVO Fertility stock, see the IVF Stock Forecast page.
Spark’s Take on IVF Stock
According to Spark, TipRanks’ AI Analyst, IVF is a Neutral.
The overall stock score for INVO Fertility is primarily impacted by its financial performance, which shows revenue growth but significant operational losses and high leverage. Technical analysis indicates bearish momentum, and the valuation is unattractive due to negative earnings and no dividend yield. These factors contribute to a low overall score.
To see Spark’s full report on IVF stock, click here.
More about INVO Fertility
INVO Fertility, Inc. operates in the fertility industry, focusing on innovative reproductive technologies and services.
Average Trading Volume: 4,631,082
Technical Sentiment Signal: Strong Sell
Current Market Cap: $2.97M
For an in-depth examination of IVF stock, go to TipRanks’ Overview page.